Meridian Bioscience Inc (VIVO) - Medical Equipment - Deals and Alliances Profile

Date: July 17, 2017
Pages: 53
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: M5710578C0AEN
Leaflet:

Download PDF Leaflet

Meridian Bioscience Inc (VIVO) - Medical Equipment - Deals and Alliances Profile
Summary

Meridian Bioscience Inc (Meridian) is a fully integrated life science company that carries out the development, manufacturing and distribution of diagnostic test kits for gastrointestinal, viral, respiratory, and parasitic infectious disease indications. It also manufactures bulk antigens, antibodies, purified reagents, nucleotides and related products for use in research and diagnostic manufacturing. Meridian develops proteins and other biological materials for use in biotechnology research for new drugs and vaccines. It offers several diagnostic tests and transport media for prenatal care, respiratory infections and organ transplant infections, among other infectious disease areas. Meridian offers its products to hospitals, clinics, veterinary testing centers, reference laboratories, research centers, physician offices and diagnostics manufacturers. The company has presence in the US, Europe, Africa and the Middle East through direct offices and subsidiaries. Meridian is headquartered in Ohio, the US.

Meridian Bioscience Inc (VIVO) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Meridian Bioscience Inc, Medical Equipment Deals By Type, 2011 to YTD 2017
Meridian Bioscience Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017
Meridian Bioscience Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017
Meridian Bioscience Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017
Meridian Bioscience Inc, Medical Equipment, Deal Details
Private Equity
Telegraph Hill Partners Acquires Dynex Technologies
Partnerships
Meridian Bioscience Enters into Licensing Agreement with University of Tennessee for Electrokinetic Sensor Technology
Magellan Diagnostics Enters into Distribution Agreement with Biofirm Technologies
Microbix Biosystems Enters into Distribution Agreement with Meridian Life Science
Magellan Diagnostics Enters into Distribution Agreement with MedCaptain Medical Technology
Biohit Enters Into Distribution Agreement With Dynex Technologies
Magellan Biosciences Enters Into An Agreement With Bruker
Magellan BioScience Enters Into An Agreement With miacom diagnostics
Equity Offering
Meridian Bioscience Files Registration Statement For A Public Offering Of Securities
Acquisition
Meridian Bioscience Acquires Magellan Diagnostics for USD66 Million
Meridian Bioscience Acquires Minority Stake in Oasis Diagnostics
Thermo Fisher Scientific Acquires TREK Diagnostic Systems
Meridian Bioscience Inc - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
Apr 27, 2017: Meridian Bioscience Reports Second Quarter 2017 Operating Results
Nov 10, 2016: Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results
Oct 18, 2016: Meridian Bioscience Comments on Preliminary Fiscal 2016 Operating Results and Provides Fiscal 2017 Revenue and Earnings Guidance
Jul 28, 2016: Meridian Bioscience Reports Third Quarter 2016 Operating Results, Declares Regular Cash Dividend, and Updates Fiscal 2016 Guidance
Apr 28, 2016: Meridian Bioscience Reports Second Quarter 2016 Operating Results
Jan 27, 2016: Meridian Bioscience Reports First Quarter 2016 Operating Results
Corporate Communications
May 10, 2017: Meridian Bioscience Engages Korn Ferry to Conduct CEO Search as John A. Kraeutler Announces Plans to Retire
Legal and Regulatory
Jul 13, 2017: Meridian Bioscience Comments on Recent FDA Press Statement
Oct 03, 2016: Bioline is Certified to the ISO 13485 Quality Standard
Government and Public Interest
Jun 06, 2017: Meridian Bioscience Comments on Recent FDA Posting Related to Magellan Diagnostics
Product News
Mar 27, 2017: Bioline Launches New JetSeq DNA Quantification Kits
Feb 08, 2017: Bioline Launches New JetSeq DNA Library Preparation Kits
Feb 03, 2017: Meridian Bioscience Announces the Launch of TruQuick Rapid Tests for Asia Pacific
Jan 09, 2017: Bioline Launches the Full Range of EPIK miRNA Assays
Sep 20, 2016: Bioline Launches New SensiFAST Lyo-Ready No-ROX Mix
Aug 23, 2016: Meridian Bioscience Expands Its Portfolio and Launches First Analyte Specific Reagent (ASR) Products
Mar 03, 2016: Bioline Launches New EPIK miRNA Select Kits
Jan 26, 2016: Meridian Bioscience and Lean Continuous Improvements Collaborate to Apply Lean Principles to Recent Launch of illumigene Malaria
Jan 26, 2016: Meridian Bioscience and Lean Continuous Improvements, Collaborate to Apply Lean Principles to Recent Launch of illumigene Malaria
Jan 26, 2016: New Malaria Test, illumigene Malaria, Sets a New Gold Standard for Diagnosis
Product Approvals
Jan 26, 2016: New Malaria Test, illumigene Malaria, Sets a New Gold Standard for Diagnosis
Other Significant Developments
Jun 30, 2017: Meridian Bioscience Comments on Recent FDA Matters Related to Magellan Diagnostics
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Meridian Bioscience Inc, Medical Equipment, Key Facts, 2016
Meridian Bioscience Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017
Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Meridian Bioscience Inc, Medical Equipment Deals By Type, 2011 to YTD 2017
Meridian Bioscience Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017
Meridian Bioscience Inc, Deals By Market, 2011 to YTD 2017
Meridian Bioscience Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017
Telegraph Hill Partners Acquires Dynex Technologies
Meridian Bioscience Enters into Licensing Agreement with University of Tennessee for Electrokinetic Sensor Technology
Magellan Diagnostics Enters into Distribution Agreement with Biofirm Technologies
Microbix Biosystems Enters into Distribution Agreement with Meridian Life Science
Magellan Diagnostics Enters into Distribution Agreement with MedCaptain Medical Technology
Biohit Enters Into Distribution Agreement With Dynex Technologies
Magellan Biosciences Enters Into An Agreement With Bruker
Magellan BioScience Enters Into An Agreement With miacom diagnostics
Meridian Bioscience Files Registration Statement For A Public Offering Of Securities
Meridian Bioscience Acquires Magellan Diagnostics for USD66 Million
Meridian Bioscience Acquires Minority Stake in Oasis Diagnostics
Thermo Fisher Scientific Acquires TREK Diagnostic Systems
Meridian Bioscience Inc, Key Competitors
Meridian Bioscience Inc, Key Employees
Meridian Bioscience Inc, Other Locations
Meridian Bioscience Inc, Subsidiaries

LIST OF FIGURES

Meridian Bioscience Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017
Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Meridian Bioscience Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017
Meridian Bioscience Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017
Meridian Bioscience Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Meridian Bioscience Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017
Meridian Bioscience Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017
Meridian Bioscience Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017
Skip to top


Ask Your Question

Meridian Bioscience Inc (VIVO) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: